Disability in chronic daily headache: State of the art and future directions

Neurological Sciences

Volumn 32, Issue SUPPL. 1, 2011, Pages

  D'Amico, Domenico ^a   Grazzi, L ^a   Usai, S ^a   Raggi, A ^a   Leonardi, M ^a   Bussone, G ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Chronic daily headache (CDH); Chronic migraine; HIT 6; Medication overuse (MO); MIDAS; WHO DAS II

Indexed keywords

TOPIRAMATE;

ARTICLE; CHRONIC DAILY HEADACHE; DISABILITY; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; HIT 6 QUESTIONNAIRE; HUMAN; MIDAS QUESTIONNAIRE; MIGRAINE; PSYCHOMETRY; QUESTIONNAIRE; SCORING SYSTEM; TEST RETEST RELIABILITY; TRANSFORMED MIGRAINE;

DISABILITY EVALUATION; HEADACHE DISORDERS; HUMANS; QUESTIONNAIRES;

EID: 79960112537     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-011-0552-1     Document Type: Article

References (42)

1. Sheftell FD, Tepper SJ (2002) New paradigms in the recognition and acute treatment of migraine. Headache 42:58-69 (Pubitemid 34136613)
2. D'Amico D, Moschiano F, Usai S, Bussone G (2006) Treatment strategies in the acute therapy of migraine: Stratified care and early intervention. Neurol Sci 27:S117-S122 (Pubitemid 44390127)
3. D'Amico D, Solari A, Usai S, Progetto Cefalee Lombardia Group et al (2006) Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study. Cephalalgia 26:691-696
4. Lipton RB, Bigal ME, Stewart WF (2005) Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life. Neurology 65:S50-S58
5. Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, ErtasM, Lanteri-Minet M, Reuter U, Sánchez Del RíoM, Schoenen J, Schwalen S, vanOene J, TOPMAT-MIG-303 Investigators Group (2007) Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): A randomised, doubleblind, placebo-controlled trial. Lancet Neurol 6:1054-1062 (Pubitemid 350123606)
6. Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L (2007) The impact of migraine prevention on daily activities: A longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health Qual Life Outcomes 5:56
7. Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J (1999) Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia 19:107-114 (Pubitemid 29170106)
8. Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN (2000) Validity of the migraine disability assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain 88:41-52
9. Kosinski M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH, Batenhorst A, Cady R, Dahlöf CG, Dowson A, Tepper S (2003) A six-item short-form survey for measuring headache impact: The HIT-6. Qual Life Res 12:963-974 (Pubitemid 37386625)
10. Lipton RB, Liberman JN, Kolodner KB, Bigal ME, Dowson A, Stewart WF (2003) Migraine headache disability and healthrelated quality-of-life: A population based case-control study from England. Cephalalgia 23:441-450 (Pubitemid 36776060)
11. Bussone G, Usai S, Grazzi L, Rigamonti A, Solari A, D'Amico D (2004) Disability and quality of life in different primary headaches: Results from Italian studies. Neurol Sci 25:S105-S107 (Pubitemid 41461969)
12. Leonardi M, Steiner T, Scher A, Lipton R (2005) The global burden of migraine: Measuring disability in headache disorders with WHO's classification of functioning, disability and health (ICF). J Headache Pain 6:429-440 (Pubitemid 43078769)
13. Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA (2007) The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia 27:193-210 (Pubitemid 46354128)
14. Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8:1-96
15. Headache Classification. Subcommittee of the International Headache Society (2004) The international classification of headache disorders. Cephalalgia 24:S1-S160
16. Headache Classification Committee, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Göbel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742-746
17. Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches: Field trial of revised HIS criteria. Neurology 47:871-875
18. Lanteri-Minet M, Auray JP, El HA, Dartigues JF, Duru G, Henry P, Lucas C, Pradalier A, Chazot G, Gaudin AF (2003) Prevalence and description of chronic daily headache in the general population in France. Pain 102:143-149 (Pubitemid 36298870)
19. Bigal ME, Rapoport AM, Lipton RB, Tepper SJ, Sheftell FD (2003) Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: A comparison of chronic migraine with episodic migraine. Headache 43:336-342 (Pubitemid 36417763)
20. Meletiche DM, Lofland JH, Young WB (2001) Quality-of-life differences between patients with episodic and transformed migraine. Headache 41:573-578 (Pubitemid 32619261)
21. D'Amico D, Usai S, Grazzi L, Rigamonti A, Solari A, Leone M, Bussone G (2003) Quality of life and disability in primary chronic daily headaches. Neurol Sci 24:S97-S100 (Pubitemid 36675556)
22. D'Amico D, Grazzi L, Usai S, Rigamonti A, Curone M, Bussone G (2005) Disability pattern in chronic migraine with medication overuse: A comparison with migraine without aura. Headache 45:553-560 (Pubitemid 40847180)
23. Bigal ME, Serrano D, Reed M, Lipton RB (2008) Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment. Neurology 71:559-566
24. Cassidy EM, Tomkins E, Hardiman O, O'Keane V (2003) Factors associated with burden of primary headache in a specialty clinic. Headache 43:638-644 (Pubitemid 36828801)
25. Magnoux E, Freeman MA, Zlotnik G (2008) MIDAS and HIT-6 French translation: Reliability and correlation between tests. Cephalalgia 28:26-34 (Pubitemid 350212652)
26. Lanteri-Minet M, Chautard MH, Lucas C (2005) Chronic migraine and medication overuse: Results of Framig 3, a French population-based survey carried out according to the 2004 IHS classification. Neurology Suppl. 2:A132
27. Grazzi L, Andrasik F, D'Amico D, Usai S, Kass S, Bussone G (2004) Disability in chronic migraine patients with medication overuse: Treatment effects at 1-year follow-up. Headache 44:678-683 (Pubitemid 38931899)
28. Andrasik F, Grazzi L, Usai S, Kass S, Bussone G (2010) Disability in chronic migraine with medication overuse: Treatment effects through 5 years. Cephalalgia 30:610-614
29. Mathew NT, Kailasam J, Meadors L (2002) Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate. Headache 42:796-803 (Pubitemid 35291515)
30. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group (2007) Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebo-controlled study. Cephalalgia 27:814-823 (Pubitemid 46961730)
31. Christie SN, Giammarco R, Gawel M, Mackie G, Gladstone J, Becker WJ (2010) Botulinum toxin type A and acute drug costs in migraine with triptan overuse. Can J Neurol Sci 37:588-594
32. Usai S, Grazzi L, D'Amico D, Andrasik F, Bussone G (2008) Reduction in the impact of chronic migraine with medication overuse after day-hospital withdrawal therapy. Neurol Sci 29:S176-S178 (Pubitemid 351836995)
33. Castillo J, Munoz P, Guitera V, Pascual G (1999) Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache 39:190-196 (Pubitemid 29190083)
34. Grazzi L, Andrasik F (2006) Medication-overuse headache: Description, treatment, and relapse prevention. Curr Pain Headache Rep 10:71-77
35. Buse DC, Manack A, Serrano D, Turkel C, Lipton RB (2010) Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 81:428-432
36. D'Amico D (2010) Pharmacological prophylaxis of chronic migraine: A review of double-blind placebo-controlled trials. Neurol Sci 31:S23-S28
37. World Health Organization (2001) The International Classification of Functioning, Disability and Health-ICF. WHO, Geneva
38. Leonardi M, Bickenbach J, Ustun TB,Kostanjsek N. Chatterji S, MHADIE consortium (2006) The definition of disability: What is in a name? Lancet 368:1219-1221 (Pubitemid 44485780)
39. Garin O, Ayuso-Mateos JL, Almansa J, Nieto M, Chatterji S, Vilagut G, Alonso J, Cieza A, Svetskova O, Burger H, Racca V, Francescutti C, Vieta E, Kostanjsek N, Raggi A, Leonardi M, Ferrer M, MHADIE consortium (2010) Validation of the World Health Organization Disability Assessment Schedule (WHODAS- 2) in patients with chronic diseases. Health Qual Life Outcomes 8:51
40. Federici S, Meloni F, Mancini A, Lauriola M, Olivetti Belardinelli M (2009) World Health Organisation Disability Assessment Schedule II: Contribution to the Italian validation. Disabil Rehabil 31:553-556
41. Leonardi M, Raggi A, Bussone G, D'Amico D (2010) Healthrelated quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center. Headache 50:1576-1586
42. Raggi A, Leonardi M, Bussone G, D'Amico D (2011) Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with healthrelated quality of life. Neurol Sci doi:10.1007/s10072-010-0466-3